Language
Search
News
- Bruker Introduces Novel Fourier 300, a Compact, Easy-to-Use 300 MHz NMR
- Bruker Corporation Reports Record Financial Results for the Fourth Quarter and Full Year 2009
- Bruker Announces Over 100 Systems Orders Received in the Second Half of 2009 from Global Stimulus...
- Bruker Announces Framework Agreement for EPR e-scan™ Beer Analyzers to Enable New Levels of Quality...
- World’s First 1000 MHz NMR Spectrometer Now Offers New Research Capabilities to European...
Upcoming Events
Metabolomics
Metabolic Profiling and Fingerprinting
Disease, drugs (and other biologically active molecules) perturb concentration and fluxes in intermediary metabolic pathways. The response involves adjustment of intracellular and extra cellular environments in order to maintain homeostasis. Both perturbation and adjustment are expressed as changes in the normal patterns in bio fluids of tissues that are characteristic (a ‘fingerprint’) of the nature of the site of the disease process, toxic insult, and pharmacological response of genetic modification. These patterns can be evaluated using spectroscopic techniques combined with multivariate statistical methods to gain insight into the response of a biological system to these perturbations in a time-related manner.
Clinical Research - Screening for Inborn Errors of Metabolism
NMR can help to diagnose metabolic disorders in newborns and children.
The fruit juice industry needs sophisticated analytical control of authenticity and legal conformity
Metabolomics is a systems approach for studying in vivo metabolic profiles, which promises to provide information on drug toxicity for pharmaceutical research.